Carson Wealth (CWM LLC)’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
Other funds holding KYNB
AC
VCM
VFT
Carson Wealth (CWM LLC)'s KYNB Position: Q1 2026 in Review
Carson Wealth (CWM LLC) held its Kyntra Bio (KYNB) position steady in Q1 2026 at 26 shares worth $176. The position accounts for ﹤0.01% of the portfolio, ranked #5542.
Carson Wealth (CWM LLC) first reported a position in KYNB in Q1 2019 and has held it in 28 quarters since. The position peaked at $17K in Q2 2021. 32 funds tracked by Wall St. Rank hold KYNB as of Q1 2026.
- Carson Wealth (CWM LLC) held 26 shares of Kyntra Bio worth $176 as of Q1 2026.
- Carson Wealth (CWM LLC) left its Kyntra Bio share count unchanged in Q1 2026.
- Kyntra Bio made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5542 holding.
- Carson Wealth (CWM LLC) first reported a position in Kyntra Bio in Q1 2019 and has held it in 28 quarters since.
- Carson Wealth (CWM LLC)'s Kyntra Bio position peaked at $17K in Q2 2021.
- 32 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.